Diets · Metabolic & Cardiometabolic
dietary linoleic acid / seed oils causes insulin resistance and metabolic dysfunction
In plain terms: Do seed oils high in omega-6 cause insulin resistance and metabolic problems?
Part of: 🔍 seed oils
Controlled human trials and pooled biomarker data show linoleic acid is neutral-to-beneficial for insulin sensitivity and lowers diabetes risk, so the insulin-resistance claim leans strongly against the evidence in humans.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
The evidence (13)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Norris 2009 · Am J Clin Nutr | RCT | contradicts | moderate | High-linoleic safflower oil improved glycemic control (lower HbA1c, fasting glucose) in obese postmenopausal women with type 2 diabetes. |
| Almolafikh ST 2026 · Metabolites | in-vitro | tested-null | low | In human mesenchymal stem cell-derived adipocytes, a 1:3 omega-3:omega-6 ratio (i.e., omega-6 dominant, 20:60 uM) produced the most favorable (lean) adipocyte phenotype versus more omega-6-skewed or neutral ratios, while unhealthy AT expansion was linked to 'e |
| Al Sinani M 2026 · BMC Pregnancy Childbirth | observational | contradicts | low | In pregnant Omani women, gestational diabetes (GDM, associated with insulin resistance) was linked to LOWER omega-3 and lower arachidonic acid/DHA levels; cord erythrocytes of GDM women also showed significantly lower LA, arachidonic acid, DHA, and total n-6 F |
| Marklund 2019 · Circulation | observational | contradicts | high | Higher linoleic-acid biomarkers tied to lower cardiometabolic mortality across 30 cohorts, inconsistent with an insulin-resistance harm pathway. |
| Suchner U. 2026 · Nutrients | observational | supports | low | Narrative review argues excess dietary n-6 PUFA (linoleic acid), highly prevalent in the Western diet, drives PUFA-eicosanoid imbalance, impaired adipose tissue expandability, functional lipodystrophy, and insulin resistance via lipotoxicity; proposes reducing |
| Wanders 2019 · BMJ Open Diabetes Res Care | meta-analysis | contradicts | high | Meta-analysis of RCT feeding trials: plant PUFA (mainly LA) replacing SFA/carbs lowered fasting insulin and HOMA-IR; no glucose worsening. |
| Imamura 2017 · PLoS Med | observational | contradicts | high | EPIC-InterAct case-cohort found plasma linoleic acid inversely associated with incident type 2 diabetes. |
| Wu 2017 · Lancet Diabetes Endocrinol | observational | contradicts | high | Pooled 20-cohort biomarker analysis (39,740 adults): higher linoleic acid associated with significantly lower incident type 2 diabetes. |
| Schwab 2014 · Food Nutr Res | meta-analysis | contradicts | moderate | Nordic systematic review found biomarker linoleic acid inversely (suggestively) related to type 2 diabetes risk and PUFA-for-SFA replacement lowers LDL. |
| Mousavi 2021 · Diabetes Care | meta-analysis | contradicts | high | Dose-response meta-analysis of prospective cohorts found higher linoleic acid intake and biomarker levels associated with LOWER, not higher, type 2 diabetes risk. |
| Chiva-Blanch 2022 · Nutrients | observational | contradicts | moderate | In the Di@bet.es cohort linoleic acid showed no significant association with incident diabetes (neither harmful nor protective). |
| Alvheim 2012 · Obesity (Silver Spring) | animal | mixed | moderate | High-LA mouse diet induced obesity/metabolic change via endocannabinoids; mechanism exists in rodents but does not reproduce in human trials. |
| Bjermo 2012 · Am J Clin Nutr | RCT | contradicts | high | Replacing SFA with n-6 PUFA reduced liver fat (a driver of insulin resistance) without raising inflammation in abdominal obesity. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.